Skip to main content

JUVÉDERM® VOLITE™ XC Injectable Gel for Improvement in Neck Appearance

Completed · Phase 3 · NCT05316233

Conditions: Neck Lines

At a glance

Research payments reported, 2025
$23,308
U.S. investigators named
12
Sites paid
12
Planned or actual enrollment
159

About the trial

Sponsor
AbbVie
Tested
VOLITE XC (device), VOLITE XC (device)
Dates
Started 2022-05-02; completion 2024-09-12
Results posted
Yes

The cumulative effects of aging, weight change, ergonomics (i.e., "tech neck"), and environmental exposures (i.e., ultraviolet, infrared, and visible light radiation and pollution) leads to wrinkles, discoloration, laxity, and roughness of sun exposed skin. The neck is a frequently mentioned area by patients complaining about its crepey texture and deep lines. VOLITE XC is a crosslinked hyaluronic acid (HA) gel implant formulated with lidocaine that was developed to provide a safe, minimally invasive method of treating fine lines and improving skin smoothness. The purpose of this study is to assess safety and effectiveness of VOLITE XC in adults seeking improvement in neck appearance. VOL…

From ClinicalTrials.gov, last updated 2026-09-03. Full record, eligibility and contacts (opens in a new tab)

Industry funding

AbbVie Inc. reported $23,308 in research payments for this study in 2025 (12 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Aesthetic Solutions PA $4,781
  • Art of Skin MD $1,780
  • Hevia Cosmetic Dermatology $1,780
  • Rak Holdings LLC $1,780
  • Steve Yoelin MD Medical Associates Inc $1,780
  • Image Dermatology PC $1,780
  • Research Institute of the Southeast LLC $1,780
  • Aesthetic Solutions $1,780
  • Center for Dermatology and Dermatologic Surgery Management LLC $1,780
  • Skin Research Institute LLC $1,780
  • Delricht LLC DBA Delricht Research $1,700
  • Melanie PAlm MD PC $806

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.